The Neuroprotective Effect of Steroid Receptor Coactivator-Interacting Protein (SIP) in Astrocyte Model of 1-Methyl-4-Phenylpyridinium (MPP⁺)-Induced Parkinson's Disease
- PMID: 31376345
- PMCID: PMC6690214
- DOI: 10.12659/MSM.912106
The Neuroprotective Effect of Steroid Receptor Coactivator-Interacting Protein (SIP) in Astrocyte Model of 1-Methyl-4-Phenylpyridinium (MPP⁺)-Induced Parkinson's Disease
Abstract
BACKGROUND The purpose of this study was to investigate the role and mechanism of steroid receptor coactivator-interacting protein (SIP) in an astrocyte model of 1-methyl-4-phenylpyridinium (MPP⁺)-induced Parkinson's disease. MATERIAL AND METHODS To perform our study, a Parkinson's disease cell model was established by treating the rat glioblastoma cell line C6 with MPP⁺. SIP was overexpressed in C6 cells using SIP-plasmid. Cell viability and apoptosis were analyzed using MTT assay and flow cytometer respectively. Tumor necrosis factor (TNF)-alpha and interleukin (IL)-1ß levels were detected using enzyme linked immunosorbent assay and quantitative reverse transcription PCR. Besides, lactate dehydrogenase (LDH) release, reactive oxygen species (ROS) production, and superoxide dismutase (SOD) enzyme activity were determined in the present study. For protein and mRNA detection, western blot assay, and qRT-PCR were performed respectively. RESULTS SIP was decreased in MPP⁺-induced C6 cells. SIP overexpression relieved MPP⁺-induced cytotoxicity of C6 cells, displayed as increased cell viability and reduced cell apoptosis and reduced LDH release. Besides, SIP inhibited MPP⁺-induced inflammatory response and oxidative stress, evidenced by decreased levels of inflammatory factors (TNF-alpha and IL-1ß), reduced ROS generation and enhanced SOD activity. Moreover, MPP⁺-induced nuclear factor-kappaB activation was inhibited by SIP overexpression. CONCLUSIONS SIP was downregulated in Parkinson's disease and it played a protective role in the development Parkinson's disease, thus may be a promising target for Parkinson's disease treatment.
Conflict of interest statement
None.
Figures







Similar articles
-
MiR-212 Attenuates MPP⁺-Induced Neuronal Damage by Targeting KLF4 in SH-SY5Y Cells.Yonsei Med J. 2018 May;59(3):416-424. doi: 10.3349/ymj.2018.59.3.416. Yonsei Med J. 2018. PMID: 29611404 Free PMC article.
-
miR-124-3p attenuates MPP+-induced neuronal injury by targeting STAT3 in SH-SY5Y cells.Exp Biol Med (Maywood). 2017 Dec;242(18):1757-1764. doi: 10.1177/1535370217734492. Epub 2017 Sep 29. Exp Biol Med (Maywood). 2017. PMID: 28958159 Free PMC article.
-
Genkwanin suppresses MPP+-induced cytotoxicity by inhibiting TLR4/MyD88/NLRP3 inflammasome pathway in a cellular model of Parkinson's disease.Neurotoxicology. 2021 Dec;87:62-69. doi: 10.1016/j.neuro.2021.08.018. Epub 2021 Sep 2. Neurotoxicology. 2021. PMID: 34481870
-
The transient receptor potential melastatin 2: a new therapeutical target for Parkinson's disease?Neural Regen Res. 2023 Aug;18(8):1652-1656. doi: 10.4103/1673-5374.360343. Neural Regen Res. 2023. PMID: 36751775 Free PMC article. Review.
-
The Role of Astrocyte Dysfunction in Parkinson's Disease Pathogenesis.Trends Neurosci. 2017 Jun;40(6):358-370. doi: 10.1016/j.tins.2017.04.001. Epub 2017 May 17. Trends Neurosci. 2017. PMID: 28527591 Free PMC article. Review.
Cited by
-
Effects of Medicinal Plants and Flavonoids on Parkinson's Disease: A Review on Basic and Clinical Evidences.Adv Pharm Bull. 2021 Feb;11(2):224-232. doi: 10.34172/apb.2021.026. Epub 2020 Jul 1. Adv Pharm Bull. 2021. PMID: 33880344 Free PMC article. Review.
-
FOXA1 Suppresses Endoplasmic Reticulum Stress, Oxidative Stress, and Neuronal Apoptosis in Parkinson's Disease by Activating PON2 Transcription.Neurotox Res. 2024 Jun 27;42(4):31. doi: 10.1007/s12640-024-00709-z. Neurotox Res. 2024. PMID: 38935306
-
Matrix Remodeling Associated Genes (MXRAs): structural diversity, functional significance, and therapeutic potential in tumor microenvironments.Discov Oncol. 2025 May 20;16(1):833. doi: 10.1007/s12672-025-02728-4. Discov Oncol. 2025. PMID: 40394417 Free PMC article. Review.
References
-
- Katunina EA, Titova NV, Malykhina EA, et al. [Oxidative stress and Parkinson’s disease: Mechanisms and perspectives of treatment]. Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115:141–45. [in Russian] - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous